Combination of HER2-Targeted Antibodies (Trastuzumab plus Pertuzumab) is Effective Against HER2 Amplified Ovarian Cancer Xenograft Models

S. P. Langdon; A. H. Sims; D. J. Harrison

Combination of HER2-Targeted Antibodies (Trastuzumab plus Pertuzumab) is Effective Against HER2 Amplified Ovarian Cancer Xenograft Models

S. P. Langdon, A. H. Sims, D. J. Harrison

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	25-25
Number of pages	1
Journal	The Journal of Pathology
Volume	231
Publication status	Published - Sept 2013
Event	7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland - Edinburgh, United Kingdom Duration: 18 Jun 2013 → 21 Jun 2013

Cite this

@article{92368ece08a349d792aa09bb0f8e5024,

title = "Combination of HER2-Targeted Antibodies (Trastuzumab plus Pertuzumab) is Effective Against HER2 Amplified Ovarian Cancer Xenograft Models",

author = "Langdon, {S. P.} and Sims, {A. H.} and Harrison, {D. J.}",

year = "2013",

month = sep,

language = "English",

volume = "231",

pages = "25--25",

journal = "The Journal of Pathology",

issn = "0022-3417",

publisher = "Wiley",

note = "7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland ; Conference date: 18-06-2013 Through 21-06-2013",

}

TY - JOUR

T1 - Combination of HER2-Targeted Antibodies (Trastuzumab plus Pertuzumab) is Effective Against HER2 Amplified Ovarian Cancer Xenograft Models

AU - Langdon, S. P.

AU - Sims, A. H.

AU - Harrison, D. J.

PY - 2013/9

Y1 - 2013/9

M3 - Meeting abstract

SN - 0022-3417

VL - 231

SP - 25

EP - 25

JO - The Journal of Pathology

JF - The Journal of Pathology

T2 - 7th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland

Y2 - 18 June 2013 through 21 June 2013

ER -